Metcalfe David A 4
4 · NEXTGEN HEALTHCARE, INC. · Filed Dec 2, 2022
Insider Transaction Report
Form 4
Metcalfe David A
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2022-12-01$14.07/sh+20,256$285,002→ 193,551 total - Exercise/Conversion
Stock Option (right to buy)
2022-12-01−20,256→ 87,234 totalExercise: $14.07Exp: 2025-10-31→ Common Stock (20,256 underlying) - Sale
Common Stock
2022-12-01$20.58/sh−32,372$666,135→ 161,179 total
Footnotes (3)
- [F1]Pursuant to a 10b5-1(c) plan adopted by the reporting person on March 15, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.48 to $20.87. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
- [F3]Original grant of 140,000 options granted on 10/31/2017 vested in four equal, annual installments beginning 10/31/2018.